CAM
BHC icon

Claret Asset Management’s Bausch Health BHC Stock Holding History

Claret Asset Management’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-18,379
Closed -$512K – 182
2021
Q3 		$512K Sell
18,379
-241
-1% -$6.83K 0.09% 107
2021
Q2 		$546K Sell
18,620
-2,223
-11% -$67.3K 0.09% 111
2021
Q1 		$662K Buy
20,843
+1,613
+8% +$47.3K 0.12% 94
2020
Q4 		$400K Sell
19,230
-359
-2% -$6.7K 0.08% 124
2020
Q3 		$304K Buy
19,589
+355
+2% +$6.12K 0.07% 134
2020
Q2 		$352K Buy
19,234
+2,821
+17% +$49.7K 0.08% 123
2020
Q1 		$254K Buy
16,413
+471
+3% +$11.4K 0.07% 131
2019
Q4 		$477K Buy
15,942
+228
+1% +$5.93K 0.09% 115
2019
Q3 		$343K Buy
15,714
+324
+2% +$7.41K 0.07% 137
2019
Q2 		$388K Buy
15,390
+639
+4% +$15.2K 0.08% 126
2019
Q1 		$364K Buy
14,751
+1,245
+9% +$29.7K 0.07% 134
2018
Q4 		$249K Sell
13,506
-3,440
-20% -$81.8K 0.06% 153
2018
Q3 		$435K Sell
16,946
-2,801
-14% -$64.1K 0.08% 120
2018
Q2 		$459K Buy
+19,747
New +$408K 0.09% 111

Other funds holding BHC

IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
PIP
Permian Investment Partners Dallas, Texas $905M AUM 13.43% 1-Year Est. Return

Claret Asset Management's BHC Position: Q4 2021 in Review

Claret Asset Management sold out of Bausch Health (BHC) in Q4 2021, closing a stake of 18,379 shares — an estimated $512K sold.

Claret Asset Management first reported a position in BHC in Q2 2018 and held it in 14 quarters. The position peaked at $662K in Q1 2021. 377 funds tracked by Wall St. Rank hold BHC as of Q4 2021.

  • Claret Asset Management reported no remaining Bausch Health position as of Q4 2021 after selling out during the quarter.
  • Claret Asset Management sold 18,379 Bausch Health shares in Q4 2021, an estimated $512K.
  • Claret Asset Management first reported a position in Bausch Health in Q2 2018 and held it in 14 quarters.
  • Claret Asset Management's Bausch Health position peaked at $662K in Q1 2021.
  • 377 funds tracked by Wall St. Rank held Bausch Health as of Q4 2021.

Based on Claret Asset Management's 13F filing for Q4 2021, filed 7 Feb 2022.